Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 13/1/2021
SIETES contiene 93213 citas

 1 a 8 de 8 
Presentar resultados
Seleccionar todas
Schwartz GG, Olsson AG, Abt M, Mallantyne CM, Barter PJ, Brumm J, Chatman BR, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJV, Mundi H, Nicholis SJ, Shah PK, Tardif JC, Wright RS, for the dal-OUTCOMES Investigators. Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med 2012;367:2089-99. [Ref.ID 94165]
2. Cita con resumen
Goldberger JJ, Bonow RO, Cuffe M, Dyer A, Rosenberg Y, O'Rourke R, Shah PK, Smith Jr SC, for the PACE-MI Investigators. ß-blocker use following myocardial infarction: low prevalence of evidence-based dosing. Am Heart J 2010;160:435-43. [Ref.ID 89225]
Dhesi P, Ng R, Shehata MM, Shah PK. Ventricular tachycardia after ingestion of Ayurveda herbal antidarrheal medication containing Aconitum. Arch Intern Med 2010;170:303-5. [Ref.ID 87851]
Eshaghian S, Amin S, Shah PK, Diamond GA. Role of clopidogrel in managing atherothrombotic cardiovascular disease. Ann Intern Med 2007;146:434-41. [Ref.ID 79711]
Tung R, Kaul S, Diamond GA, Shah PK. Narrative review: drug-eluting stents for the management of restenosis: a critical appraisal of the evidence. Ann Intern Med 2006;144:913-9. [Ref.ID 77367]
6. Cita con resumen
Cercek B, Shah PK, Noc M, Zahger D, Zeymer U, Matetzky S, Maurer G, Mahrer P, for AZACS Investigators. Effect of short-term treatment with azithromycin on recurrent ischaemic events in patients with acute coronary syndrome in the Azithromycin in Acute Coronary Syndrome (AZACS) trial: a randomised controlled trial. Lancet 2003;361:809-13. [Ref.ID 65292]
7.Tiene citas relacionadas Cita con resumen
Shah PK. Sildenafil in the treatment of erectile dysfunction. N Engl J Med 1998;339:699. [Ref.ID 40087]
Furst SD, Fallon SP, Reznik G N, Shah PK. Myocardial infarction after inhalation of methamphetamine. N Engl J Med 1990;323:1147. [Ref.ID 15594]
Seleccionar todas
 1 a 8 de 8